Fore Capital, LLC Bristol Myers Squibb CO Transaction History

Fore Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $887,550 - $1.04 Million	-15,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $928,650 - $1.01 Million	15,000 New	15,000 $1 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.86 Million - $2.7 Million	-40,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.71 Million - $2.03 Million	-40,000 Reduced 50.0%	40,000 $2.03 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $3.57 Million - $3.95 Million	80,000 New	80,000 $3.63 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fore Capital, LLC with notifications on news.